Click here to close now.




















Welcome!

News Feed Item

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spastic Cerebral Palsy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Spastic Cerebral Palsy 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Spastic Cerebral Palsy Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Medy-Tox Inc. 29
Clinical Trial Overview of Medy-Tox Inc. 29
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Top Institutes / Government 32
All India Institute of Medical Sciences 32
Clinical Trial Overview of All India Institute of Medical Sciences 32
Gujarat Ayurved University 33
Clinical Trial Overview of Gujarat Ayurved University 33
Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Clinical Trial Overview of Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Duke University Medical Center 35
Clinical Trial Overview of Duke University Medical Center 35
Wright State University 36
Clinical Trial Overview of Wright State University 36
ALYN Pediatric and Adolescent Rehabilitation Center 37
Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center 37
Erasmus MC 38
Clinical Trial Overview of Erasmus MC 38
Chang Gung Memorial Foundation 39
Clinical Trial Overview of Chang Gung Memorial Foundation 39
National Center for Complementary and Alternative Medicine 40
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 40
Stanford University 41
Clinical Trial Overview of Stanford University 41
Five Key Clinical Profiles 42
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Spastic Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spastic Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Spastic Cerebral Palsy Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014* 29
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 30
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 31
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 32
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2014* 33
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Istituti Clinici Di Perfezionamento, 2014* 34
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2014* 35
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Wright State University, 2014* 36
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2014* 37
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 38
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 39
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 40
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 41

List of Figures

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 58


Read the full report:
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
SYS-CON Events announced today that Micron Technology, Inc., a global leader in advanced semiconductor systems, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Micron’s broad portfolio of high-performance memory technologies – including DRAM, NAND and NOR Flash – is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of tech...
This Enterprise Strategy Group lab validation report of the NEC Express5800/R320 server with Intel® Xeon® processor presents the benefits of 99.999% uptime NEC fault-tolerant servers that lower overall virtualized server total cost of ownership. This report also includes survey data on the significant costs associated with system outages impacting enterprise and web applications. Click Here to Download Report Now!
SYS-CON Events announced today that Pythian, a global IT services company specializing in helping companies leverage disruptive technologies to optimize revenue-generating systems, has been named “Bronze Sponsor” of SYS-CON's 17th Cloud Expo, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Founded in 1997, Pythian is a global IT services company that helps companies compete by adopting disruptive technologies such as cloud, Big Data, advance...
SYS-CON Events announced today the Containers & Microservices Bootcamp, being held November 3-4, 2015, in conjunction with 17th Cloud Expo, @ThingsExpo, and @DevOpsSummit at the Santa Clara Convention Center in Santa Clara, CA. This is your chance to get started with the latest technology in the industry. Combined with real-world scenarios and use cases, the Containers and Microservices Bootcamp, led by Janakiram MSV, a Microsoft Regional Director, will include presentations as well as hands-on...
Cloud and datacenter migration innovator AppZero has joined the Microsoft Enterprise Cloud Alliance Program. AppZero is a fast, flexible way to move Windows Server applications from any source machine – physical or virtual – to any destination server, in any cloud or datacenter, using its patented container technology. AppZero’s container is also called a Virtual Application Appliance (VAA). To facilitate Microsoft Azure onboarding, AppZero has two purpose-built offerings: AppZero SP for Azure,...
Organizations from small to large are increasingly adopting cloud solutions to deliver essential business services at a much lower cost. According to cyber security experts, the frequency and severity of cyber-attacks are on the rise, causing alarm to businesses and customers across a variety of industries. To defend against exploits like these, a company must adopt a comprehensive security defense strategy that is designed for their business. In 2015, organizations such as United Airlines, Sony...
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
Consumer IoT applications provide data about the user that just doesn’t exist in traditional PC or mobile web applications. This rich data, or “context,” enables the highly personalized consumer experiences that characterize many consumer IoT apps. This same data is also providing brands with unprecedented insight into how their connected products are being used, while, at the same time, powering highly targeted engagement and marketing opportunities. In his session at @ThingsExpo, Nathan Trel...
Red Hat is investing in Tesora, the number one contributor to OpenStack Trove Database as a Service (DBaaS) also ranked among the top 20 companies contributing to OpenStack overall. Tesora, the company bringing OpenStack Trove Database as a Service (DBaaS) to the enterprise, has announced that Red Hat and others have invested in the company as a part of Tesora's latest funding round. The funding agreement expands on the ongoing collaboration between Tesora and Red Hat, which dates back to Febr...
IBM’s Blue Box Cloud, powered by OpenStack, is now available in any of IBM’s globally integrated cloud data centers running SoftLayer infrastructure. Less than 90 days after its acquisition of Blue Box, IBM has integrated its Blue Box Cloud Dedicated private-cloud-as-a-service into its broader portfolio of OpenStack® based solutions. The announcement, made today at the OpenStack Silicon Valley event, further highlights IBM’s continued support to deliver OpenStack solutions across all cloud depl...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
Through WebRTC, audio and video communications are being embedded more easily than ever into applications, helping carriers, enterprises and independent software vendors deliver greater functionality to their end users. With today’s business world increasingly focused on outcomes, users’ growing calls for ease of use, and businesses craving smarter, tighter integration, what’s the next step in delivering a richer, more immersive experience? That richer, more fully integrated experience comes ab...
With the proliferation of connected devices underpinning new Internet of Things systems, Brandon Schulz, Director of Luxoft IoT – Retail, will be looking at the transformation of the retail customer experience in brick and mortar stores in his session at @ThingsExpo. Questions he will address include: Will beacons drop to the wayside like QR codes, or be a proximity-based profit driver? How will the customer experience change in stores of all types when everything can be instrumented and a...
Culture is the most important ingredient of DevOps. The challenge for most organizations is defining and communicating a vision of beneficial DevOps culture for their organizations, and then facilitating the changes needed to achieve that. Often this comes down to an ability to provide true leadership. As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership ab...